ES2721535T3 - Procedimiento de purificación de virus a gran escala - Google Patents

Procedimiento de purificación de virus a gran escala Download PDF

Info

Publication number
ES2721535T3
ES2721535T3 ES15816413T ES15816413T ES2721535T3 ES 2721535 T3 ES2721535 T3 ES 2721535T3 ES 15816413 T ES15816413 T ES 15816413T ES 15816413 T ES15816413 T ES 15816413T ES 2721535 T3 ES2721535 T3 ES 2721535T3
Authority
ES
Spain
Prior art keywords
virus
gradient
purification procedure
virus purification
percentage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15816413T
Other languages
English (en)
Inventor
Pascal Gerkens
Jean-Francois Leruse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
KM Biologics Co Ltd
Original Assignee
GlaxoSmithKline Biologicals SA
KM Biologics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA, KM Biologics Co Ltd filed Critical GlaxoSmithKline Biologicals SA
Application granted granted Critical
Publication of ES2721535T3 publication Critical patent/ES2721535T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16051Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Un procedimiento de purificación de un virus que comprende al menos las siguientes etapas: a) obtener un fluido que contiene virus, b) proporcionar un gradiente de densidad lineal preformado de un intervalo dado X% -Y% (v/p) (siendo X el límite inferior y Y el límite superior) en un rotor de centrífuga con una capacidad de al menos 8 L, c) agregar el fluido al gradiente de densidad lineal preformado, d) centrifugar para separar el virus de las impurezas contaminantes, y e) recolectar las fracciones que comprenden el virus purificado, en el que la parte lineal del gradiente del intervalo dado X%-Y% abarca el porcentaje de densidad correspondiente al porcentaje, en el gradiente, en el que el virus que se purificará migrará.
ES15816413T 2014-12-16 2015-12-14 Procedimiento de purificación de virus a gran escala Active ES2721535T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462092413P 2014-12-16 2014-12-16
PCT/EP2015/079534 WO2016096688A1 (en) 2014-12-16 2015-12-14 A method for a large scale virus purification

Publications (1)

Publication Number Publication Date
ES2721535T3 true ES2721535T3 (es) 2019-08-01

Family

ID=55024091

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15816413T Active ES2721535T3 (es) 2014-12-16 2015-12-14 Procedimiento de purificación de virus a gran escala

Country Status (6)

Country Link
US (1) US20170369854A1 (es)
EP (1) EP3234113B1 (es)
JP (1) JP6719468B2 (es)
BE (1) BE1023903B1 (es)
ES (1) ES2721535T3 (es)
WO (1) WO2016096688A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108949671A (zh) * 2018-08-02 2018-12-07 重庆市畜牧科学院 鹌鹑成纤维细胞培养基及其制备方法
CN113025584A (zh) * 2019-12-09 2021-06-25 上海青赛生物科技有限公司 狂犬病毒纯化方法与应用
CN112704733A (zh) * 2020-12-29 2021-04-27 深圳康泰生物制品股份有限公司 四价流感病毒鸡胚尿囊液纯化工艺、四价流感病毒裂解疫苗及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5310356Y2 (es) * 1973-08-03 1978-03-18
US4118477A (en) * 1977-02-14 1978-10-03 Merck & Co., Inc. Hepatitis B antigen
DK0382271T3 (da) 1989-02-04 1995-05-01 Akzo Nobel Nv Tocoler som adjuvanser i vacciner
FR2808803B1 (fr) 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CN104694489A (zh) 2007-05-04 2015-06-10 巴克斯特国际公司 用于病毒纯化用连续超速离心的糖溶液配方
FR2918074B1 (fr) 2007-06-27 2009-10-09 Sanofi Pasteur Procede de purification d'une suspension virale.
EP2393922A1 (en) * 2009-02-06 2011-12-14 GlaxoSmithKline Biologicals S.A. Purification of virus or viral antigens by density gradient ultracentrifugation

Also Published As

Publication number Publication date
WO2016096688A1 (en) 2016-06-23
US20170369854A1 (en) 2017-12-28
JP6719468B2 (ja) 2020-07-08
BE1023903A1 (fr) 2017-09-07
EP3234113B1 (en) 2019-01-23
JP2018500023A (ja) 2018-01-11
BE1023903B1 (fr) 2017-09-08
EP3234113A1 (en) 2017-10-25

Similar Documents

Publication Publication Date Title
DK3394393T3 (da) Olie-, vand-, gas- og faststofpartikelseparering inden for olie- og/eller gasproduktion
BR112015016136A2 (pt) métodos para isolar microvesículas
CR20160078A (es) Asiento para bicicleta
BR112014032177A2 (pt) separador
CL2017000404A1 (es) Rueda pelton
AR091538A1 (es) Purificacion de particulas tipo virus
JP2016182547A5 (es)
UA115769C2 (uk) Пристрій для відведення текучого середовища пристроєм центрифугування
ES2721535T3 (es) Procedimiento de purificación de virus a gran escala
AR089463A1 (es) Metodo y aparato para retener una brida en un medidor de flujo
AR097627A1 (es) Métodos y dispositivos para la codificación conjunta de canales múltiples
DK3440310T3 (da) Faststofpartikelseparering inden for olie- og/eller gasproduktion
TW201614209A (en) Collection component and sample processing kit having the same
DK3242933T3 (da) Genetisk modificeret mesenkymale stamceller udtrykkende alfa-1 antitrypsin (AAT)
AR104737A1 (es) Reconfiguración en una red de malla inalámbrica
DK3548099T3 (da) Ovn til kontinuerlig fjernelse af plantesundhedsmæssige skadevoldere, der forekommer i organiske partikler af vegetabilsk oprindelse
FR3007038B1 (fr) Polypeptide ayant la capacite de former des branchements d'unites glucosyle en alpha-1,3 sur un accepteur
BR112015020041A2 (pt) coletor de pó, e, método de remoção de partículas do ar sujo
ES2466571A8 (es) Membrana cerámica de filtración
AR102853A1 (es) Purificación de gelatina
CL2018000076A1 (es) Mejora del metabolismo de las microalgas de xilosa.
EA201991117A1 (ru) Системы и способы улучшенного поддержания высокоэффективной конфигурации с обращенным полем с вакуумированием с захватом многомасштабного типа
EA201692555A1 (ru) Применение декстрансульфата, имеющего среднюю молекулярную массу менее 10000 да, для индуцирования ангиогенеза у субъекта
MY179359A (en) Methods for purification of a virus produced in vitro and clearance assay for the virus
JP2017535495A5 (es)